Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1024, 2004-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept/infliximab: Tuberculosis in patients with latent tuberculosis infections: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. :
Adalimumab/etanercept/infliximab: Salmonella infections: 17 case reports
Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Etanercept/infliximab: Neutropenia: case report
Reactions Weekly, Vol. 1, Iss. 1166, 2007-01 ,pp. :
Etanercept/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :